Submit Deal

Yoshihiro Nakagawa

General Counsel at TAKEDA PHARMACEUTICAL COMPANY LIMITED

Manager

Deal Bio

Total Deals6

Valued Deals6

Total Value£8,894M

Avg. Deal Size£1,482M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (6)

Sort

Japan

Pharmaceuticals

AcquisitionPrivateMajority

target

XIIDRA

bidder

Novartis

£4,066m

52 dealmakers

United States

Pharmaceuticals

AcquisitionPrivateMajorityCross Border

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

Japan

Health Care Services

PrivateAcquisitionMajorityPrivate EquityCross Border

target

Takeda Consumer Healthcare Company

bidder

Blackstone Group

£1,756m

38 dealmakers

Japan

Medical Equipment

MajorityPrivateCross BorderAcquisitionPrivate Equity

target

Takeda (tachosil)

bidder

Gtcr

£320m

78 dealmakers

United States

Biotechnology

Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

United States

Pharmaceuticals

PrivateMajorityAcquisitionCross Border

target

Maverick Therapeutics

bidder

Takeda Pharmaceutical Company

£379m

12 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy